| [1] Early Breast Cancer Trialists' collaborative Group(EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials[J]. Lancet, 2005,365(9472):1687-1717.[2] Rabaglio M, Aebi S, Castiglione-Gertsch M. Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St. Gallen conference[J]. Lancet Oncol, 2007,8:940-949.[3] Althuis M D, Fergenbaum J H, Garcia-Closas M, et al. Etiology of hormone receptor-defined breast cancer: A systematic review of the literature[J]. Cancer Epidemiol Biomarkers Prev, 2004,13(10):1558.[4] Crudden G, Chitti R E, Craven R J. Hpr6(heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs[J]. J Pharmacol Exp Ther, 2006,316(1):448-455.[5] 纪术峰,吴爱国,杨华峰.孕激素膜受体1在乳腺癌的表达及生物学意义[J].南方医科大学学报,2012,32(5):635-638.[6] Causey M W, Huston L J, Harold D M, et al. Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging[J]. J Surg Res, 2011,171(2):615-622.[7] Neubauer H, Clare S E, Wozny W, et al. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1[J]. Breast Cancer Res, 2008,10(5):R85[8] Peluso J J, Pappalardo A, Losel R, et al. Expression and function of PAIRBP1 within gonadotropin-primed immature rat ovaries: PAIRBP1 regulation of granulosa and luteal cell viability[J]. Biol Reprod, 2005,73(2):261-270.[9] Crudden G, Loesel R, Craven R J. Overexpression of the cytochrome p450 activator hpr6(heme-1 domain protein/human progesterone receptor) in tumors[J]. Tumour Biol, 2005,26(3):142-146.[10] Cahill M A. Progesterone receptor membrane component 1: an integrative review[J]. J Steroid Biochem Mol Biol, 2007,105(1-5):16-36.[11] Neubauer H, Adam G, Seeger H, et al. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells[J]. Climacteric, 2009,12(3):230-239.[12] Neubauer H, Yang Y, Seeger H, et al. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells[J]. Menopause, 2011,18(8):845-850.[13] Stanczyk F Z. Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women's Health Initiative trial be explained by progesterone receptor membrane component 1?[J]. Menopause, 2011,18(8):833-834.[14] Ruan X, Neubauer H, Yang Y, et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells[J]. Climacteric, 2012,15(5):467-472.[15] Ruan X, Schneck H, Schultz S, et al. Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells[J]. Gynecol Endocrinol, 2012,28(11):863-866.[16] Ruan X, Seeger H, Mueck A O. The pharmacology of nomegestrol acetate[J]. Maturitas(J of the European Society of Menopause and Andropause), 2012,71(4):345-353.[17] Ruan X, Seeger H, Mueck A O. The pharmacology of dienogest[J]. Maturitas(J of the European Society of Menopause and Andropause), 2012,71(4):337-344.[18] Hand R A, Craven R J. Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells[J]. J Cell Biochem, 2003,90(3):534-547.[19] Cahill M A. Progesterone receptor membrane component 1: an integrative review[J]. J Steroid Biochem Mol Biol, 2007,105(1-5):16-36.[20] Swiatek-De Lange M, Stampfl A, Hauck S M, et al. Membrane-initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells[J]. Glia, 2007,55(10):1061-1073.[21] Olsen J V, Blagoev B, Gnad F, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks[J]. Cell, 2006,127(3):635-648.[22] Liu L, Wang J, Zhao L, et al. Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2[J]. Endocrinology, 2009,150(7):3186-3196.[23] Liu L, Wang J, Zhao L, et al. Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2[J]. Endocrinology, 2009,150(7):3186-3196.[24] Song B L, De Bose-Boyd R A. Ubiquitination of 3-hydroxy-3-methylglutaryl-CoA reductase in permeabilized cells mediated by cytosolic E1 and a putative membrane-bound ubiquitin ligase[J]. J Biol Chem, 2004,279(27):28798-28806.[25] Suchanek M, Radzikowska A, Thiele C. Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells[J]. Nat Methods, 2005,2(4):261-267.[26] Lee J N, Song B, DeBose-Boyd R A, et al. Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78[J]. J Biol Chem, 2006,281(51):39308-39315.[27] Ahmed I S, Rohe H J, Twist K E, et al. Pgrmcl(progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinil sensitivity[J]. J Biol Chem, 2010,285(32):24775-24782.[28] Zachariades E, Mparmpakas D, Thomas P, et al. Crucial cross-talk of interleukin-1β and progesterone in human choriocarcinoma[J]. Int J Oncol, 2012,40(5):1358-1364.[29] 夏想厚,谷俊朝.乳腺癌新辅助内分泌治疗的研究进展[J].中华肿瘤防治杂志,2010,17(24):2066-2069.[30] 吴晖,欧阳取长,曾亮.年轻女性乳腺癌临床特点及其预后分析[J].中华肿瘤防治杂志,2010,17(14):1104-1107. |
